Biocodex is a family-owned pharmaceutical company that provides innovative healthcare solutions to patients in 115 countries worldwide. Founded in 1953 to market the world’s first probiotic yeast strain for human medicine, Saccharomyces boulardii CNCM I-745®, the company now provides a wide range of products in microbiota care, women’s health and orphan diseases. We are committed to our mission, we are proud of our teams, we are united by shared values. They are our driving forces allowing us to grow while remaining agile.
Present in more than 115 countries, Biocodex’s 1,664 employees are committed to serving millions of patients around the world. We apply our expertise to developing and marketing a wide range of products to meet patient needs, focusing on three pillars: Microbiota care, women’s health and orphan diseases.